Over 30 Total Lots Up For Auction at Two Locations - WI 05/27, NV 05/29

Dr. Benjamin Movsas

Society of Chairs of Academic Radiation Oncology Programs elects president
July 24, 2018
ASTRO Rad Oncology Radiation Therapy
Dr. Movsas Benjamin
DETROIT – Benjamin Movsas, M.D., Chair of the Department of Radiation Oncology at the Henry Ford Cancer Institute, has been named President of the American Society for Radiation Oncology’s (ASTRO) Society of Chairs of Academic Radiation Oncology Programs (SCAROP).

His one-year term as SCAROP President began in Summer 2018. Dr. Movsas previously served as SCAROP’s Vice President.

SCAROP is comprised of a group of national leaders in radiation oncology. The society provides a forum for the chairs of academic radiation oncology programs to discuss issues of common interest and to foster an interchange of ideas to help shape the future vision and direction of the field.
stats
DOTmed text ad

We repair MRI Coils, RF amplifiers, Gradient Amplifiers and Injectors.

MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013

stats
Dr. Movsas is a recognized leader in radiation oncology, stereotactic radiation, lung cancer, prostate cancer, and quality of life issues pertaining to cancer.

He was recently named President-Elect of the American Radium Society (ARS); he assumes the role of ARS President in Spring 2019. He also serves as co-chair of the NCI Patient Centered Outcomes Research (PCOR) committee for the NRG clinical trial cooperative group.

He has published extensively on the topic of radiation therapy for cancer in many prestigious medical journals and regularly presents his research findings at some of the nation’s top medical meetings.

Ranked as one of American’s top cancer doctors, Dr. Movsas has been featured in Consumer’s Guide to Top Doctors, HOUR Detroit’s Top Docs, and the Castle Connolly’s America’s Top Doctors for Cancer. He also is a Fellow of both the American Society of Radiation Oncology (ASTRO) and of the American College of Radiology (ACR).

Dr. Movsas received his undergraduate degree from Harvard University and his medical degree from the Washington University School of Medicine.


About the Henry Ford Cancer Institute
The Henry Ford Cancer Institute is one of the largest cancer programs in Michigan, providing care at five hospitals and six outpatient facilities, and dozens of aligned doctor’s offices throughout southeast and southcentral Michigan. Treatment for the most complex or rare cancers and the Institute’s extensive cancer research program is anchored by Henry Ford Hospital.

You Must Be Logged In To Post A Comment

 

classifieds

Rad Oncology Homepage

UT Southwestern starts construction on $177 million radiation oncology facility in Texas
The 65,000-square-foot facility will include four linear accelerators
FDA expands clearance for P-Cure proton therapy system to full-body and supine treatments
Gantry-less architecture enables installation in vaults originally designed for linear accelerators
TriHealth partners with RevealDx to advance lung nodule assessment using AI
Adds AI-driven decision support to expanding lung cancer program
RaySearch launches RayStation v2025 with expanded auto-planning
Adds support for treatment planning using the Leo Cancer Care upright patient positioning system
GE HealthCare adds AI-driven tools to radiation oncology portfolio
Plans to integrate software from Spectronic Medical into portfolio
P-Cure opens second Israel facility to scale compact proton therapy production
Will handle manufacturing and assembly of the company’s proprietary accelerator technology
Sun Nuclear acquires AI software firm Oncospace to bolster radiation oncology tools
Integrates predictive analytics and cloud-based planning solutions
Penn Medicine to add $224 million proton center, ramp up FLASH research
Will house two ProteusONE proton therapy systems from IBA in a 43,000-square-foot space
Will you be attending this year's National Proton Conference?
Q&A with Jennifer Maggiore, the National Association for Proton Therapy’s (NAPT) executive director
Varian and Embolx to jointly market embolization microcatheter in US
Expanding interventional oncology portfolio with a focus on liver-directed therapies